Press Release Summary:
NICORE Advantage External Counterpulsation (ECP) System provides non-invasive cardiac care therapy with intelligent features that enable automatic operation. In addition to tracking patient outcomes, system integrates with information technology systems through seamless HL7 interface and allows remote clinical and technical support. Product also provides tools required to comply with HIPAA privacy regulations and safety certification to UL60601.
Original Press Release:
ScottCare Introduces NICORE Advantage
Advanced ECP system is designed for today's demanding clinical environment
CLEVELAND, March 13 -- ScottCare Corporation, a leader in non-invasive cardiology products, today unveiled NICORE Advantage, an External Counterpulsation (ECP) system designed to deliver effective therapy and seamlessly integrate with information technology systems, track patient outcomes and improve efficiency for clinicians.
ScottCare is demonstrating this new, advanced technology at the 2006 American College of Cardiology (ACC) annual meeting March 11-14, 2006, in Atlanta, Georgia.
NICORE Advantage opens the door to new revenue opportunities while addressing today's demanding clinical environment. Benefits of the system include:
- Unmatched Productivity -- Intelligent features make operation easy and automatic including system generated peak-to-peak ratios.
- Integrated Outcomes -- Tracks and reports on individual and group Outcomes including exclusive integrated quality of life surveys.
- Regulatory Compliance -- Provides tools required to comply with HIPAA privacy regulations and safety certification to UL60601.
- Comprehensive Information Technology Solution -- Integrates with information systems through a seamless HL7 interface and allows remote clinical and technical support from ScottCare service headquarters.
"Cardiology professionals are being squeezed by declining reimbursements and ever more stringent regulation. NICORE Advantage enables our customers to do what they do best: help their patients," said Ken Zajaczkowski, President of ScottCare Corporation. "ScottCare sees a bright future in ECP and will continue to invest technology and clinical innovation to improve the quality of life for cardiac patients."
NICORE ECP systems are used by hundreds of hospitals and office practices across the country, providing clinicians with a proven, non-invasive cardiac care therapy to improve the health and quality of life for cardiac patients. Clinical studies have demonstrated that ECP therapy benefits more than 80% of patients treated, with significant improvement in relief of the symptoms of angina and heart failure, increased functional capacity, and reduced dependence on medication.
Consistent with ScottCare's philosophy of customer care, installed users of ScottCare's NICORE, NCP-2 and NCP-1 systems will have the opportunity to upgrade to Advantage.
For more information on this new system, call 1-800-243-9412, ext. 128 or visit www.scottcare.com.
About ScottCare Corporation
ScottCare Corporation, a leader in non-invasive cardiology therapy and rehabilitation, has manufactured quality medical devices serving cardiopulmonary professionals since 1989. Based in Cleveland, Ohio, ScottCare is a division of the Scott Fetzer Company, a wholly-owned subsidiary of Berkshire Hathaway, Inc. of Omaha, Nebraska.
CONTACT: Bill Kulp, Director of Product-Market Development of ScottCare Corporation, +1-216-362-0550, ext. 133